Home > Boards > US Listed > Biotechs > Aurinia Pharmaceuticals Inc (AUPH)

I also remember Israeli scientists proclaimed a breakthrough

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Plegee Member Profile
 
Followed By 2
Posts 113
Boards Moderated 0
Alias Born 08/17/06
160x600 placeholder
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/20/2020 5:02:28 PM
Aurinia Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 11/20/2020 5:00:00 PM
Aurinia Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference Business Wire - 11/12/2020 4:05:00 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/10/2020 4:03:42 PM
Aurinia Reports Third Quarter 2020 Financial Results and Recent Operational Highlights Business Wire - 11/10/2020 4:02:00 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/9/2020 4:06:20 PM
Aurinia Presents Integrated Time to Renal Response Data from the AURA-LV & AURORA Trials, along with Voclosporin Drug-Drug In... Business Wire - 11/9/2020 4:05:00 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/2/2020 4:06:28 PM
Aurinia Announces Outcome of AUDREY™ Clinical Trial in Dry Eye Syndrome Business Wire - 11/2/2020 4:05:00 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 10/29/2020 9:00:57 AM
Aurinia Announces European Investigator-Initiated Trial to Evaluate Antiviral Activity of Voclosporin in Kidney Transplant Re... Business Wire - 10/27/2020 4:05:00 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 10/22/2020 5:16:15 PM
Aurinia Presents Voclosporin Efficacy & Pharmacokinetic Data from Integrated Analysis of AURA-LV & AURORA Pivotal Trials at A... Business Wire - 10/22/2020 4:15:00 PM
Aurinia Pharmaceuticals Announces Launch of Lupus Nephritis Disease-State Awareness Initiative for Healthcare Professionals, ... Business Wire - 10/14/2020 6:05:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/2/2020 5:02:43 PM
Aurinia Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 10/2/2020 5:00:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/28/2020 6:07:52 AM
Aurinia Completes Final Patient Treatment in AUDREY Phase 2/3 Clinical Trial of Voclosporin Ophthalmic Solution for Dry Eye S... Business Wire - 9/28/2020 6:05:00 AM
Aurinia Pharmaceuticals to Present at Three Upcoming Virtual Investor Conferences Business Wire - 9/10/2020 6:05:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/8/2020 6:01:21 AM
Aurinia Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 9/4/2020 6:04:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/11/2020 4:05:41 PM
Aurinia Reports Second Quarter 2020 Financial Results and Recent Operational Highlights Business Wire - 8/11/2020 4:02:00 PM
Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference Business Wire - 8/4/2020 6:05:00 AM
Aurinia Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 11, 2020 Business Wire - 7/30/2020 6:05:00 AM
Plegee   Friday, 02/28/20 07:57:50 PM
Re: thesaud post# 10477
Post # of 11410 
I also remember Israeli scientists proclaimed a breakthrough for a cancer cure last year as well. Any vaccine research/experience will be helpful for the next viral crisis, but this one will have run its course by the time a vaccine is ready in necessary quantity. However, feel this current outbreak is far from over, and there will be many more sensationalized headlines to come so the investment banker algos can continue to pillage retail; thereby offsetting some of their bonus options share price loses.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences